Trypsin inhibitor, 500 mg

5-amino-2-isobutyl-1H-isoindole-1,3(2H)-dione, 95.0%, 1g

3,5-bis(trifluoromethyl)benzoylacetonitrile, 97.0%, 5g

ethyl 3-{[3-(dimethylamino)-2,2-dimethylpropyl]amino}propanoate, 95.0%, 2g

2-bromo-1H-imidazo[4,5-b]pyridine, 97%, 100mg

4-Fluoro-benzo[d]isoxazol-3-ylamine, 95.0%, 250mg

1-(2-BROMO-3,4-DIFLUOROPHENYL)METHANAMINE HYDROCHLORIDE, 95%, 100mg

4-Methyl-1-nitro-2-(trifluoromethyl)benzene, 95.0%, 25g

3-(4-Benzyloxy-3-methoxyphenyl)-4-phenyl-1,2,4-triazoline-5-thione, 95%, 10g

Ethyl 4-bromo-2-fluorobenzoate, 95.0%, 25g

7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid, 95.0%, 100mg

(2-Hydroxyethyl)dimethyl(3-sulfopropyl)ammonium Hydroxide Inner Salt [for Biochemical Research]>98.0%(HPLC)(N)1g

2-Ethoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>97.0%(GC)(T)5g